A germline mutation of the KIF1Bβ gene on 1p36 in a family with neural and nonneural tumors

Human Genetics

Volumn 124, Issue 3, 2008, Pages 279-285

  Yeh, I Tien ^a,b   Lenci, Romina E ^b   Qin, Yuejuan ^b   Buddavarapu, Kalyan ^b   Ligon, Azra H ^c,d   Leteurtre, Emmanuelle ^e   Cao, Christine Do ^e   Cardot Bauters, Catherine ^e   Pigny, Pascal ^e   Dahia, Patricia L M ^a,b  

^a University of Texas Health Science Center at San Antonio   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMIC ACID; KINESIN; KINESIN FAMILY MEMBER 1B BETA; NEUROFIBROMIN; PROTEIN RET; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADRENALECTOMY; ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 1P; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GANGLIONEUROMA; GENE DOSAGE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; LUNG ADENOCARCINOMA; MALE; MUTATIONAL ANALYSIS; NEURAL CREST; NEUROBLASTOMA; OXIDATIVE STRESS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; WILD TYPE;

ADENOCARCINOMA; ADULT; CHROMOSOMES, HUMAN, PAIR 1; FAMILY HEALTH; FEMALE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; KINESIN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NERVOUS SYSTEM NEOPLASMS; NEURONS; PHEOCHROMOCYTOMA;

EID: 53749107898     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-008-0553-1     Document Type: Article

References (19)

1. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812-8818
2. Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N, Wemeau JL, Proye C, Pigny P (2003) Hereditary phaeochromocytomas and paragangliomas: A study of five susceptibility genes. J Med Genet 40:e75
3. Creighton C, Hanash S, Beer D (2003) Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas. FEBS Lett 540:167-170
4. Dahia PLM, Hao K, Rogus J, Colin C, Pujana MAG, Ross K, Magoffin D, Aronin N, Cascon A, Hayashida CY, Li C, Toledo SPA, Stiles CD, Consortium. ftFP (2005a) Novel pheochromocytoma susceptibility loci identified by integrative genomics. Cancer Res 65:9651-9658
5. Dahia PLM, Ross K, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, Hodin R, Heitritter S, Moore Jr F, Dluhy R, Sosa JA, IT O, Benn DE, Marsh DJ, Robinson BG, Schneider K, Garber J, Arum SM, Korbonits M, Grossman A, Pigny P, Toledo SPA, Nosé V, Li C, Stiles CD (2005b) A HIF1a regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1:e8
6. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, Raza A, Root DE, Attar E, Ellis SR, Golub TR (2008) Identification of RPS14 as a 5q-syndrome gene by RNA interference screen 451:335-339
7. Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L (2007) Secondary sarcomas in childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 99:300-308
8. Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M, Sasaki T, Ozawa S (2002) Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971-978
9. 2+ -permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 27:7987-8001
10. Knudson AG (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
11. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG Jr, Schlisio S (2005) Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer. Cancer Cell 8:155-167
12. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764
13. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G, Baudin E, Chompret A, Ellison JW, Briere JJ, Rustin P, Gimenez-Roqueplo AP, Eng C, Carney JA, Stratakis CA (2008) Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 16:79-88
14. Ramanujan VK, Biener-Ramanujan E, Armmer K, Centonze VE, Herman BA (2006) Spectral kinetics ratiometry: A simple approach for real-time monitoring of fluorophore distributions in living cells. Cytometry A 69:912-919
15. Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, Carter BD, Kaelin WG Jr (2008) The kinesin KIF1B{beta} acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev
16. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) From the cover: Gene set enrichmeAt analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550
17. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, Shah K, Sato M, Thomas RK, Barletta JA, Borecki IB, Broderick S, Chang AC, Chiang DY, Chirieac LR, Cho J, Fujii Y, Gazdar AF, Giordano T, Greulich H, Hanna M, Johnson BE, Kris MG, Lash A, Lin L, Lindeman N, Mardis ER, McPherson JD, Minna JD, Morgan MB, Nadel M, Orringer MB, Osborne JR, Ozenberger B, Ramos AH, Robinson J, Roth JA, Rusch V, Sasaki H, Shepherd F, Sougnez C, Spitz MR, Tsao MS, Twomey D, Verhaak RG, Weinstock GM, Wheeler DA, Winckler W, Yoshizawa A, Yu S, Zakowski MF, Zhang Q, Beer DG, Wistuba II, Watson MA, Garraway LA, Ladanyi M, Travis WD, Pao W, Rubin MA, Gabriel SB, Gibbs RA, Varmus HE, Wilson RK, Lander ES, Meyerson M (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898
18. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokawa N (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105:587-597
19. Zuchner S, Vance JM (2006) Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease. Neuromolecular Med 8:63-74